SCOPUS 정보 검색 플랫폼

Volumn 46, Issue 3, 2002, Pages 909-912

Extent of cross-resistance between agents used to treat human immunodeficiency virus type 1 infection in clinically derived isolates

(2) Harrigan, P Richard a Larder, Brendan A a

a Visible Genetics (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ANTIBIOTIC SENSITIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD SAMPLING; CROSS RESISTANCE; DERIVATIZATION; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHENOTYPIC VARIATION; PRESCRIPTION; PRIORITY JOURNAL; VIRUS ISOLATION;

ANTI-HIV AGENTS; DRUG RESISTANCE, MICROBIAL; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; PHENOTYPE; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE INHIBITORS; UNITED STATES;

EID: 0036174444 PISSN: 00664804 EISSN: None Source Type: Journal
DOI: 10.1128/AAC.46.3.909-912.2002 Document Type: Article

Times cited : (31)

References (9)

1
- 0035281213
- Nonnucleoside reverse transcriptase inhibitor resistance
- (2001) J. Acquir. Immune Defic. Syndr. , vol.26 , Issue.SUPPL. 1
- Deeks, S.G.¹

2
- 0001393927
- Antiretroviral drug resistance in HIV-1
- (1999) Curr. Infect. Dis. Rep. , vol.1 , pp. 289-297
- Hanna, G.J.¹ D'Aquila, R.T.²

3
- 0344474694
- A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs
- (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 269-276
- Hertogs, K.¹ De Béthune, M.-P.² Miller, V.³ Ivens, T.⁴ Schel, P.⁵ Van Cauwenberge, A.⁶ Van Den Eynde, C.⁷ Van Gerwen, V.⁸ Azijn, H.⁹ Van Houtte, M.¹⁰ Peeters, F.¹¹ Staszewski, S.¹² Conant, M.¹³ Bloor, S.¹⁴ Kemp, S.¹⁵ Larder, B.¹⁶ Pauwels, R.¹⁷

4
- 0033803407
- Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy
- (2000) Clin. Infect. Dis. , vol.30 , Issue.SUPPL. 1
- Kaplan, J.E.¹ Hanson, D.² Dworkin, M.S.³ Frederick, T.⁴ Bertolli, J.⁵ Lindegren, M.L.⁶ Holmberg, S.⁷ Jones, J.L.⁸

5
- 0035281108
- Nucleoside reverse transcriptase inhibitor resistance
- (2001) J. Acquir. Immune Defic. Syndr. , vol.26 , Issue.SUPPL. 1
- Loveday, C.¹

6
- 0035280944
- Resistance to protease inhibitors
- (2001) J. Acquir. Immune Defic. Syndr. , vol.26 , Issue.SUPPL. 1
- Miller, V.¹

7
- 0032731970
- Natural history of HIV infection in the era of combination antiretroviral therapy
- (1999) AIDS , vol.13 , pp. 1933-1942
- Moore, R.D.¹ Chaisson, R.E.²

8
- 2642709177
- Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
- (1998) N. Engl. J. Med. , vol.338 , pp. 853-860
- Palella Jr., F.J.¹ Delaney, K.M.² Moorman, A.C.³ Loveless, M.O.⁴ Fuhrer, J.⁵ Satten, G.A.⁶ Aschman, D.J.⁷ Holmberg, S.D.⁸

9
- 0034011309
- Human immunodeficiency virus type-1 protease inhibitors: Therapeutic successes and failures, suppression and resistance
- (2000) Pharmacol. Ther. , vol.86 , pp. 145-170
- Swanstrom, R.¹ Eron, J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.